Olverembatinib
Olverembatinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Olverembatinib is under investigation in clinical trial NCT03883100 (A Pivotal Study of Olverembatinib in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation).
| Trade Name | Olverembatinib |
| Generic | HQP1351 |
| HQP1351 Other Names | Hqp-1351 free base, Hqp1351 free base, Olverembatinib |
| Type | |
| Formula | C29H27F3N6O |
| Weight | Average: 532.571 Monoisotopic: 532.219844002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Olverembatinib
